Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Sequenom Cutting 12% of Jobs

By R&D Editors | August 20, 2013

Sequenom Inc., which makes the MaterniT21 genetic test, said that it is laying off 75 employees, or about 12 percent of its workforce, to cut costs as it struggles to collect revenue from insurers, Medicare and Medicaid.
 
Last month, the San Diego company posted disappointing second-quarter results as it ran nearly triple the number of tests, but had problems collecting revenue. It blamed billing code changes made by insurers and the Centers for Medicare and Medicaid Services for the delays. It also said some state Medicaid plans no longer cover its diagnostic tests.
 
Since peaking at a 52-week high of $5.36 at the start of this year, the shares have zigzagged lower and recently tumbled to a year-low of $2.86.
 
Sequenom said that it has notified most of the employees that will be affected and plans to inform the rest by Friday. The move will cost about $1.2 million in severance expenses during the third quarter, but Sequenom said in a regulatory filing that it will save about $10 million a year from the layoffs and other departures that occurred during July. The company had 594 workers as of March, according to its 10K filing.
 
Sequenom said it expects to see the benefit of its cost cuts during the fourth quarter.
 
Date: August 19, 2013
Source: Associated Press

Related Articles Read More >

Carnyx targets 2027 IND filing for oral sleep candidate CNYX-005
Illustration of a folded protein with three amino acid substitutions labeled: leucine to glycine, cysteine to aspartate and serine to phenylalanine.
Twist adds cell-free antibody screening for AI-designed candidates
Schematic of the M2PC lab interior showing rows of Ginkgo Bioworks automated instrument carts for media prep, strain engineering, cell culturing, functional testing, sample prep and phenotyping analysis, linked by automated connectivity
PNNL breaks ground on a 100-instrument autonomous microbe lab that will open to outside researchers in 2029
Two RFD4-Proteina-designed enzymes that break down the pesticide paraoxon, with their structural accuracy and catalytic efficiency.
NVIDIA and UW’s protein design model produces 158 binders from 188 designs
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2026 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE